Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 83Pancreatic Neoplasms 33Stomach Neoplasms 32Rectal Neoplasms 23Colonic Neoplasms 22Neoplasms 20Neoplasm Metastasis 19Esophageal Neoplasms 16Cholangiocarcinoma 14Adenocarcinoma Of Esophagus 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Non-Small-Cell Lung 12Burkitt Lymphoma 12Biliary Tract Neoplasms 12Adenocarcinoma 11Gastrointestinal Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Leukemia, Biphenotypic, Acute 5Gallbladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Advanced Solid Tumors 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Leukemia 4Carcinoma, Renal Cell 4Appendiceal Neoplasms 4Urinary Bladder Neoplasms 3

Interventions

pembrolizumab 6Cetuximab 5olaparib 3atezolizumab 3Injections 3fludarabine 2Trastuzumab 2Docetaxel 2Cyclophosphamide 2Bevacizumab 2zimberelimab 1zansecimab 1tocilizumab 1taxane 1spartalizumab 1somatostatin receptor 2 1ribociclib 1pralsetinib 1pertuzumab 1pegylated granulocyte colony-stimulating factor 1lenvatinib 1ipatasertib 1inavolisib 1fludarabine phosphate 1entrectinib 1encorafenib 1durvalumab 1dapagliflozin 1cemiplimab 1brigimadlin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Solid Tumors × Leucovorin × 1 year × Clear all
NCT07415031 2026-05-15

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Mirati Therapeutics Inc.

Phase 2 Recruiting
170 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡